Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 933 shares of the business’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $108.31, for a total value of $101,053.23. Following the sale, the executive vice president now directly owns 27,595 shares in the company, valued at $2,988,814.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of Varian Medical Systems, Inc. (NYSE:VAR) opened at $109.32 on Thursday. Varian Medical Systems, Inc. has a 52 week low of $76.94 and a 52 week high of $114.09. The firm has a market capitalization of $10,020.00, a P/E ratio of 39.61, a price-to-earnings-growth ratio of 3.29 and a beta of 0.68.

Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). The business had revenue of $739.00 million for the quarter, compared to the consensus estimate of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.03 EPS. equities analysts anticipate that Varian Medical Systems, Inc. will post 4.11 EPS for the current fiscal year.

Several equities research analysts have weighed in on VAR shares. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, October 29th. Royal Bank of Canada set a $105.00 price objective on Varian Medical Systems and gave the stock a “hold” rating in a research note on Thursday, November 30th. Citigroup boosted their price objective on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research note on Monday, October 30th. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Finally, Evercore ISI started coverage on Varian Medical Systems in a research note on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. Varian Medical Systems has a consensus rating of “Hold” and a consensus target price of $100.44.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Varian Medical Systems by 1.7% during the second quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock valued at $944,980,000 after buying an additional 150,482 shares during the last quarter. BlackRock Inc. grew its stake in shares of Varian Medical Systems by 6.6% during the second quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock valued at $869,233,000 after buying an additional 523,858 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of Varian Medical Systems by 2.1% during the third quarter. First Eagle Investment Management LLC now owns 4,778,741 shares of the medical equipment provider’s stock valued at $478,161,000 after buying an additional 99,270 shares during the last quarter. Janus Henderson Group PLC grew its stake in shares of Varian Medical Systems by 1,545.7% during the second quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock valued at $387,450,000 after buying an additional 3,526,571 shares during the last quarter. Finally, APG Asset Management N.V. grew its stake in shares of Varian Medical Systems by 106.1% during the third quarter. APG Asset Management N.V. now owns 1,669,419 shares of the medical equipment provider’s stock valued at $167,042,000 after buying an additional 859,400 shares during the last quarter.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 933 Shares of Stock” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/01/18/insider-selling-varian-medical-systems-inc-var-evp-sells-933-shares-of-stock.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.